News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
224,854 Results
Type
Article (5007)
Company Profile (17)
Press Release (219830)
Section
Business (82196)
Career Advice (461)
Deals (15041)
Drug Delivery (8)
Drug Development (19062)
Employer Resources (30)
FDA (3675)
Job Trends (3900)
News (120096)
Policy (7499)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (292)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14761)
ALS (19)
Alzheimer's disease (245)
Antibody-drug conjugate (ADC) (11)
Approvals (3692)
Artificial intelligence (39)
Autoimmune disease (3)
Automation (2)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (46)
Cancer (429)
Cardiovascular disease (21)
Career advice (392)
Career pathing (2)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16012)
Collaboration (162)
Compensation (159)
Complete response letters (2)
COVID-19 (302)
CRISPR (7)
C-suite (95)
Cystic fibrosis (16)
Data (498)
Depression (5)
Diabetes (39)
Diagnostics (2037)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40739)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37682)
Executive appointments (292)
FDA (3919)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (177)
Gene editing (15)
Generative AI (2)
Gene therapy (48)
GLP-1 (106)
Government (410)
Guidances (16)
Healthcare (5035)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (318)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7819)
IRA (3)
Job creations (1120)
Job search strategy (360)
Kidney cancer (6)
Labor market (4)
Layoffs (100)
Leadership (5)
Legal (2331)
Liver cancer (17)
Lung cancer (52)
Lymphoma (28)
Management (10)
Manufacturing (46)
MASH (27)
Medical device (3857)
Medtech (3858)
Mergers & acquisitions (7417)
Metabolic disorders (117)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (336)
NextGen: Class of 2025 (1674)
Non-profit (727)
Northern California (889)
Now hiring (2)
Obesity (52)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (13)
Parkinson's disease (25)
Partnered (4)
Patents (22)
Patient recruitment (27)
Peanut (5)
People (24539)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4773)
Phase II (6951)
Phase III (5544)
Pipeline (532)
Policy (7)
Postmarket research (625)
Preclinical (1865)
Press Release (66)
Prostate cancer (26)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (64)
Real estate (1873)
Recruiting (8)
Regulatory (5106)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (25)
Series B (22)
Sickle cell disease (7)
Southern California (678)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (3)
Startups (1007)
Stomach cancer (1)
Supply chain (10)
Tariffs (2)
United States (6785)
Vaccines (35)
Venture capitalists (2)
Webinars (4)
Weight loss (20)
Women's health (1)
Date
Today (29)
Last 7 days (142)
Last 30 days (846)
Last 365 days (10180)
2025 (2671)
2024 (11027)
2023 (13193)
2022 (18660)
2021 (19680)
2020 (18239)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12118)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8796)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11435)
Australia (1604)
California (1858)
Canada (676)
China (69)
Colorado (79)
Connecticut (91)
Delaware (28)
Europe (24460)
Florida (260)
Georgia (32)
Idaho (23)
Illinois (110)
India (6)
Indiana (61)
Iowa (1)
Japan (65)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (216)
Massachusetts (1499)
Michigan (84)
Minnesota (136)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (12)
Nevada (22)
New Hampshire (15)
New Jersey (542)
New Mexico (5)
New York (459)
North Carolina (319)
North Dakota (2)
Northern California (889)
Ohio (54)
Oklahoma (5)
Oregon (3)
Pennsylvania (333)
Rhode Island (12)
South America (276)
South Carolina (4)
Southern California (678)
Tennessee (35)
Texas (219)
Utah (57)
Virginia (42)
Washington D.C. (9)
Washington State (165)
West Virginia (2)
Wisconsin (20)
224,854 Results for "aphios corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aphios Granted US Patent for Thermal Conversion of CBDA and Other Carboxylic Acid Cannabinoids
January 15, 2025
·
1 min read
Genetown
Aphios Granted US Patent For siRNA Targeted Therapeutics for Treatment of HIV-1 and Other Diseases
Aphios Corporation announced today that it has been granted US Patent No. 11,981,174 for CCR5 and CD4 siRNA-targeted therapeutics for treatment of HIV-1 and other diseases.
May 15, 2024
·
2 min read
Press Releases
Aphios Awarded NIH SBIR Grant For Development of Anti-CCR5 Nanoparticles to Treat Alzheimer’s Disease
December 11, 2024
·
1 min read
Genetown
Aphios Awarded NIH Grant For Development of a Double-Encapsulated mRNA Vaccine for COVID-19 and Other Diseases
Aphios announced today that it was awarded an NIH grant to develop a double encapsulated mRNA vaccine for COVID-19 and other diseases.
May 23, 2023
·
2 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Genetown
Aphios Granted US Patent For Combination HIV Latency Nanoparticles Towards an HIV Cure
Aphios Corporation announced today that it has been granted US Patent No. 11,234,932 for treating HIV latency towards an HIV cure.
February 8, 2022
·
2 min read
Genetown
Aphios Granted Chinese Patent for Novel Bryoid to Treat Alzheimer’s Disease
Aphios Corporation today announced that it has been granted Chinese Patent No. 201811111996.8 by China National Intellectual Property Administration on October 26, 2021.
November 10, 2021
·
1 min read
Genetown
Aphios® Pharma LLC to Host Webinar on the Business of Cannabis as a Pharmaceutical Medicine on Thursday, July 14, 2022 at 12:00 pm EST
Aphios ® Pharma LLC to Host Webinar on the Business of Cannabis as a Pharmaceutical Medicine on Thursday, July 14, 2022 at 12:00 pm EST.
July 7, 2022
·
2 min read
Press Releases
Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights
March 26, 2025
·
17 min read
Press Releases
Lobe Sciences Provides Corporate Update
April 7, 2025
·
8 min read
1 of 22,486
Next
